Cardinal Health (CAH) Tops Q1 EPS by 9c, Reaffirms FY18 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Cardinal Health (CAH) PT Lowered to $67 at Jefferies; Remains Sidelined
November 7, 2017 8:10 AM ESTJefferies lowered its price target on Cardinal Health (NYSE: CAH) to $67.00 (from $77.00) while maintaining a Hold rating following the company's earnings release. Despite missing consensus revenue by ~2.5% ($32.6B vs. $33.4B), CAH beat on earnings for the quarter as a result of better than expected... More
Cardinal Health (CAH) Announces CFO Mike Kaufmann as Next CEO and Board Member; Effective Jan. 1, 2018
November 6, 2017 6:59 AM ESTCardinal Health (NYSE: CAH) announced today that it has named Mike Kaufmann, 54, its current chief financial officer, to serve as the company's next chief executive officer and join the board of directors, effective Jan. 1, 2018. Kaufmann will succeed George Barrett, 62, Cardinal Health's chairman and chief executive officer since 2009, who will continue to serve as executive chairman of the board of directors through the annual meeting of shareholders in November 2018. At that time, Gregory Kenny, Cardinal Health's lead independent director, will assume the role of non-executive chairman.
Kaufmann is a 27-year veteran of Cardinal... More
